Literature DB >> 29634109

NEW SPIROHYDANTOIN DERIVATIVES - SYNTHESIS, PHARMACOLOGICAL EVALUATION, AND MOLECULAR MODELING STUDY.

Anna Czopek, Agnieszka Zagorska, Marcin Kolaczkowski, Adam Bucki, Beata Gryzlo, Joanna Rychtyk, Maciej Pawlowsk, Agata Siwek, Grzegorz Satala, Andrzej Bojarski, Monika Kubacka, Barbara Filipek.   

Abstract

A series of new arylpiperazinylpropyl derivatives of 8/6-phenyl-1,3-diazaspiro[4.5]decan-2,4-dione and spiro[imidazolidine-4,1'-indene/naphthalene]-2,5-dione was synthesized and their affinity was evaluated toward serotonin 5-HTIA, 5-HT2A, 5-HT7 receptors, dopaminergic D2, D3 receptors, adrenergic ox, receptors, and serotonin transporter (SERT). The highest affinity for serotonin 5-HT1A/2A/7 receptors was found for compounds containing a tetralin or indane moiety in the imide part. Among these, two compounds (19, 20) were selected for further pharmacological in vivo studies. A binding mode of representative molecule 19, which behaved as a 5-HT1A agonist and weak 5-HT7 antagonist in the site of 5-HT 1A/7, was also analyzed in computational stud- ies. Moreover, two highly selective (9 and HI) 5-HT₂A receptor antagonists were obtained.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 29634109

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  2 in total

1.  Impact of N-Alkylamino Substituents on Serotonin Receptor (5-HTR) Affinity and Phosphodiesterase 10A (PDE10A) Inhibition of Isoindole-1,3-dione Derivatives.

Authors:  Anna Czopek; Anna Partyka; Adam Bucki; Maciej Pawłowski; Marcin Kołaczkowski; Agata Siwek; Monika Głuch-Lutwin; Paulina Koczurkiewicz; Elżbieta Pękala; Anna Jaromin; Bożena Tyliszczak; Anna Wesołowska; Agnieszka Zagórska
Journal:  Molecules       Date:  2020-08-25       Impact factor: 4.411

2.  Novel serotonin 5-HT2A receptor antagonists derived from 4-phenylcyclohexane-5-spiro-and 5-methyl-5-phenyl-hydantoin, for use as potential antiplatelet agents.

Authors:  Anna Czopek; Monika Kubacka; Adam Bucki; Agata Siwek; Barbara Filipek; Maciej Pawłowski; Marcin Kołaczkowski
Journal:  Pharmacol Rep       Date:  2021-06-11       Impact factor: 3.024

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.